Literature DB >> 7242321

"End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients.

R P Kimberly, M D Lockshin, R L Sherman, J F Beary, J Mouradian, J S Cheigh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7242321

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  8 in total

1.  Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.

Authors:  J C Nossent; W Bronsveld; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 2.  Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature.

Authors:  Patrícia Mattos; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2012-03-14       Impact factor: 2.980

Review 3.  Prognostic factors in systemic lupus erythematosus.

Authors:  A J Swaak; J C Nossent; R J Smeenk
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

4.  Systemic lupus erythematosus in North Indian Asians. A prospective analysis of clinical and immunological features.

Authors:  A N Malaviya; R Misra; S Banerjee; A Kumar; S C Tiwari; U N Bhuyan; K K Malhotra; J S Guleria
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Why do patients with lupus nephritis die?

Authors:  P Correia; J S Cameron; J D Lian; J Hicks; C S Ogg; D G Williams; C Chantler; D G Haycock
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

6.  Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis.

Authors:  Sophia Ross; Kerstin Benz; Katja Sauerstein; Kerstin Amann; Jörg Dötsch; Katalin Dittrich
Journal:  BMC Nephrol       Date:  2012-08-06       Impact factor: 2.388

7.  Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort.

Authors:  Graciela S Alarcón; Gerald McGwin; Michelle Petri; Rosalind Ramsey-Goldman; Barri J Fessler; Luis M Vilá; Jeffrey C Edberg; John D Reveille; Robert P Kimberly
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

8.  Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.

Authors:  Maria Salgado Guerrero; Alejandra Londono Jimenez; Chrisanna Dobrowolski; Wenzhu B Mowrey; Beatrice Goilav; Shudan Wang; Anna Broder
Journal:  BMC Nephrol       Date:  2020-10-28       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.